6472 Stock Overview
Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 6/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Bora Pharmaceuticals Co., LTD. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$757.00 |
52 Week High | NT$845.00 |
52 Week Low | NT$530.45 |
Beta | 0.62 |
1 Month Change | 21.12% |
3 Month Change | 15.05% |
1 Year Change | 38.49% |
3 Year Change | 427.88% |
5 Year Change | 1,620.18% |
Change since IPO | 1,583.27% |
Recent News & Updates
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Recent updates
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?
Mar 17Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment
Feb 17New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)
Jan 27Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings
Dec 29Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?
Dec 09Shareholder Returns
6472 | TW Pharmaceuticals | TW Market | |
---|---|---|---|
7D | 0.4% | -2.2% | -1.6% |
1Y | 38.5% | 7.2% | 25.9% |
Return vs Industry: 6472 exceeded the TW Pharmaceuticals industry which returned 7.2% over the past year.
Return vs Market: 6472 exceeded the TW Market which returned 25.9% over the past year.
Price Volatility
6472 volatility | |
---|---|
6472 Average Weekly Movement | 6.2% |
Pharmaceuticals Industry Average Movement | 3.8% |
Market Average Movement | 4.6% |
10% most volatile stocks in TW Market | 8.6% |
10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6472 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6472's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | n/a | Bobby Sheng | www.bora-corp.com |
Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments.
Bora Pharmaceuticals Co., LTD. Fundamentals Summary
6472 fundamental statistics | |
---|---|
Market cap | NT$76.61b |
Earnings (TTM) | NT$3.03b |
Revenue (TTM) | NT$14.20b |
25.3x
P/E Ratio5.4x
P/S RatioIs 6472 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6472 income statement (TTM) | |
---|---|
Revenue | NT$14.20b |
Cost of Revenue | NT$7.21b |
Gross Profit | NT$6.99b |
Other Expenses | NT$3.96b |
Earnings | NT$3.03b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 29.94 |
Gross Margin | 49.23% |
Net Profit Margin | 21.34% |
Debt/Equity Ratio | 35.0% |
How did 6472 perform over the long term?
See historical performance and comparison